Skip to content

Clinical trials

Completed Thrombosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombosis Status: Completed Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20063
20081
20091
20102
20111
20123
20143
20151
20172
20182
20192
20204
20211
20223
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.4
Bayer2
First Affiliated Hospital Xi'an Jiaotong University2
Fudan University2
Sanofi2
Abbott Medical Devices1
AstraZeneca1
Beijing Chao Yang Hospital1
Beijing Huanxing Cancer Hospital1
Beijing Tiantan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombosis35
Ischemic Stroke5
Pulmonary Embolism4
Stroke4
Cardiovascular Diseases3
Coronary Artery Disease3
Inflammation3
Myocardial Infarction3
Thromboembolism3
Venous Thrombosis3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.